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Abstract
Background: By performing identical studies in humans and rats, we attempted to distinguish vulnerability factors for
addiction from neurobiological effects of chronic drug exposure. We focused on the GABAergic system within the
hippocampus, a brain region that is a constituent of the memory/conditioning neuronal circuitry of addiction that is
considered to be important in drug reinforcement behaviors in animals and craving and relapse in humans.
Methodology: Using RNA-Seq we quantified mRNA transcripts in postmortem total hippocampus from alcoholics, cocaine
addicts and controls and also from alcohol-naı ¨ve, alcohol preferring (P) and non-preferring (NP) rats selectively bred for
extremes of alcohol-seeking behavior that also show a general addictive tendency. A pathway-targeted analysis of 25
GABAergic genes encoding proteins implicated in GABA synthesis, metabolism, synaptic transmission and re-uptake was
undertaken.
Principal Findings: Directionally consistent and biologically plausible overlapping and specific changes were detected: 14/
25 of the human genes and 12/25 of the rat genes showed nominally significant differences in gene expression (global p
values: 9610
214,7 610
211 respectively). Principal FDR-corrected findings were that GABBR1 was down-regulated in
alcoholics, cocaine addicts and P rats with congruent findings in NSF, implicated in GABAB signaling efficacy, potentially
resulting in increased synaptic GABA. GABRG2, encoding the gamma2 subunit required for postsynaptic clustering of
GABAA receptors together with GPHN, encoding the associated scaffolding protein gephryin, were both down-regulated in
alcoholics and cocaine addicts but were both up-regulated in P rats. There were also expression changes specific to cocaine
addicts (GAD1, GAD2), alcoholics (GABRA2) and P rats (ABAT, GABRG3).
Conclusions/Significance: Our study confirms the involvement of the GABAergic system in alcoholism but also reveals a
hippocampal GABA input in cocaine addiction. Congruent findings in human addicts and P rats provide clues to
predisposing factors for alcohol and drug addiction. Finally, the results of this study have therapeutic implications.
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Introduction
Chronic exposure to heavy alcohol and cocaine use is known to
result in widespread neuronal adaptations. Some of these changes
may be specific to alcohol or cocaine exposure but other changes
may be more general, reflecting shared pathways in addiction. In
addition, inter-individual neurobiological variation contributes to
the heritability of addiction. We have previously published a global
analysis of differential expression of 16,008 gene transcripts that
were detected in the postmortem hippocampus of alcoholics,
cocaine addicts and controls [1]. The aim of the current study was
to distinguish changes in expression of gamma-aminobutyric acid
(GABA) pathway genes that might be unique to alcoholics or
cocaine addicts, and to identify changes common to both.
Moreover, we attempted to distinguish trait and state effects for
addiction in humans by identifying differences in GABAergic gene
expression in alcohol naı ¨ve rats selectively bred for high (P) and
low (NP) alcohol preference, a model for vulnerability to alcohol
dependence. P rats have also shown evidence for addiction
vulnerability to other substances including nicotine and cocaine
[2].
There has been increasing interest in the role of the
hippocampus in addiction, a disorder that involves changes in
neuronal circuits involved in saliency/reward, motivation/drive,
memory/conditioning and control/disinhibition [3,4]. The hip-
pocampus is implicated in long and short term episodic memory
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the memory/conditioning neuronal circuit that is considered to be
important in drug reinforcement behaviors in animals and craving
and relapse in humans [4]. Imaging studies in humans have shown
that cue-elicited craving activates the hippocampus [3]. Addictive
drugs impair neurogenesis in the adult hippocampus and there is
increasing evidence to show that this may be associated with
impairments of learning and memory [4–6]. Suppression of adult
hippocampal neurogenesis has been shown to increase cocaine
self-administration in rats [7]. Moreover, the hippocampus is part
of the default mode network, a set of brain regions that exhibit
resting state synchronized low frequency oscillations. The default
mode network is impaired in addiction and it has been suggested
that the altered resting state functional connectivity may underlie
the heightened sensitivity to drug related cues and weakened
cognitive control that is a hallmark of addiction [8]. Moreover, the
hippocampus, together with the amygdala and the frontal cortex,
sends projections to the nucleus accumbens that plays a critical
role in the acute reinforcing effects of drugs [4,9]. Hippocampal
function is determined by the balance between excitatory pyra-
midal cell firing and their modulation by GABA-containing
interneurons. Alcohol alters this balance and indeed the hip-
pocampus has been implicated in the development of alcohol
tolerance [10,11]. GABAergic inhibition and hippocampal theta
oscillations are both critical for synaptic plasticity and learning
behaviors [12]. Cocaine depresses the GABA current of hip-
pocampal neurons [13].
Rapid synaptic inhibition is mediated through GABAA
receptors that are ligand-gated, chloride ion channels. GABAB
receptors are G protein-coupled receptors that are present in
almost all CNS neurons and regulate synaptic transmission and
signal propagation. A substantial body of evidence from preclinical
studies has implicated GABAA receptors in the acute and chronic
effects of ethanol including tolerance, dependence and withdrawal
[14–16]. Preclinical studies have implicated GABAB receptors in
the rewarding effects of drugs of abuse [17,18]. Indeed, GABAB
agonists have been found to decrease alcohol consumption and
craving in humans and severity of alcohol withdrawal symptoms in
humans and rats [17,19].
Preclinical studies have shown that changes in the expression of
subunits of GABAA receptors are implicated in the development
of ethanol tolerance and dependence as well as in the cortical
excitability associated with withdrawal [14]. In this study we chose
to do a comprehensive assessment of gene expression changes in
GABAergic genes that encode proteins involved in GABA
synthesis, transmission, transport and metabolism. We compared
GABAergic gene expression in postmortem total hippocampus
from eight alcoholics, eight cocaine addicts and eight controls
using RNA-Seq, a deep-sequencing technology that maps the
entire transcriptome and provides precise, accurate measurements
of the level of transcripts [20,21]. We used the same RNA Seq
method to compare GABAergic gene expression in postmortem
total hippocampus from eight selectively bred alcohol-preferring
(P) and eight non-preferring (NP) rats.
Methods
Human hippocampal samples
Postmortem brain tissue was provided by the University of
Miami Brain Bank. Since we used publicly available pathological
specimens, our study was exempt from NIH Institutional Review
Board (IRB) review. Research protocols at the University of Miami
were approved by the University of Miami IRB. Brain tissues were
removed from autopsy cases according to criteria described by the
National Association of Medical Examiners Committee on
Cocaine-related Deaths [22,23]. Samples were limited to sudden
death without medical intervention or prolonged agonal periods.
The postmortem interval (PMI) was less than 24 hours. Brain pH
was measured as a quality control for each sample with values
.6.0. For further details see [24].
Regional samples of postmortem brain were taken from frozen
coronal blocks based on surface and cytoarchitectural landmarks.
The hippocampus was sampled bilaterally from coronal slices
taken at the anterior level of the hippocampal body, including the
dentate gyrus and the Cornu Ammonis fields CA1–CA4 and the
subiculum.
The postmortem samples were taken from eight cocaine
addicts, eight alcoholics and eight controls, all men. All subjects
in the cocaine and alcohol groups met DSM-IV criteria for abuse
or dependence. The cocaine addicts had long-standing histories
of cocaine abuse and the deaths were attributed to cocaine
intoxication. None of the cocaine addicts had a history of other
drug misuse/dependence or of alcohol misuse/dependence and
had not been drinking prior to death. The alcoholics had
histories of chronic heavy alcohol consumption and all had
enlarged livers: four had fatty livers, one had hepatic fibrosis.
None had hepatic encephalopathy. None of the alcoholics had a
history of drug misuse/dependence and a drug screen at the time
of death was negative. The controls were age-matched and drug
and alcohol free (negative urine screens, no history of licit or
illicit drug use prior to death). Based on medical examiners’
reports, next-of-kin informant reports, medical records and legal
records, none of the subjects in this study had any other
psychiatric disorders.
The mean (SD) ages were: cocaine addicts: 39.9 (4.9) yrs;
alcoholics: 36.9 (9.5) years; controls: 37.5 (6.1) years. The mean
(SD) PMIs were: cocaine addicts: 17.6 (3.0) hrs; alcoholics: 15.8
(3.5) hrs; controls: 17.1 (4.4) hrs. The ethnicity ratio: Caucasian or
Caucasian/Hispanics:African Americans was as follows: cocaine
addicts: 5:3; alcoholics: 7:1; controls: 5:3.
Hippocampal samples from P and NP rats
Hippocampal samples (total hippocampus) from selectively bred
alcohol-preferring (P) and non-preferring (NP) rats, generation
S70, were obtained from the Indiana University School of
Medicine. The P and NP lines of rats were derived from a
randomly bred, closed colony of Wistar rats by mass selection
using a two-bottle free-choice paradigm with access to 10% (V/V)
ethanol and water [25]. The sample consisted of eight alcohol
preferring (P) and eight non-preferring (NP) male alcohol-naı ¨ve
rats, all sacrificed at 90 days of age. For further details see [26].
Construction of cDNA libraries
Details of the methods for construction of cDNA libraries have
been described previously [1]. Briefly, total RNA was extracted
from homogenized human postmortem hippocampal or dissected
rat hippocampal tissue using guanidinium thiocyanate and phenol-
based RNA extraction solution and purified on RNeasy spin
columns. mRNA was isolated by oligo (dT)25 beads and
fragmented. The fragmented mRNA was reverse transcribed
and cDNA libraries were synthesized.
High-throughput, massively parallel sequencing using an
Illumina Genome Analyzer (GAIIx)
Sample preparation and sequencing on the Genome Analyzer
(Illumina, San Diego, CA) were carried out according to the
Illumina protocols with some modifications. Briefly, the double
Hippocampal GABAergic Gene Expression in Addiction
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Klenow fragment for end repair. The 59 end of the DNA
fragments were then phosphorylated by T4 polynucleotide kinase,
and an adenosine base was added to the 39 end of the fragments by
Klenow (39-59 exo
2). A universal adaptor was then added to both
ends of the DNA fragments by A-T ligation. Following 18 cycles of
PCR with the Phusion DNA polymerase, the DNA library was
then purified on a 2% agarose gel and fragments of 170–300 base-
pair in size were recovered. Around 15 ng of the DNA library was
then used for cluster generation on a grafted GAII Flow Cell, and
sequenced on the Genome Analyzer for 36 cycles using the
‘‘Sequencing-by-synthesis’’ method.
Sequence base-calling, mapping to genome, data
normalization and statistical analysis
Sequences were called from image files with the Illumina
Genome Analyzer Pipeline (GApipeline) and aligned to the
reference genome (UCSC hg18 for human and UCSC rn4 for
rat) using Extended Eland in the GApipeline. A total of 3 million
uniquely mapped RNA-Seq reads for each human and rat sample
were retrieved from export.txt files (output of Extended Eland).
Based on their mapping locations, these selected reads were parsed
with in-house Perl scripts to generate base coverage in WIG file
format. After moving average smoothing, the chromosome
locations of enrichment peaks were identified from pooled WIG
files using in-house Perl scripts. The average sequencing reads of
the most abundantly covered 50 bp in a single exon within an
annotated Ref-Seq gene were counted for each sample. The read
counts were then log2 transformed and normalized using quantile
normalization (BioConductor limma package).
Selection of candidate GABAergic genes
Table 1 lists the 25 GABAergic candidate genes that were
selected for this study. The genes encode for GABA synthesis (GLS,
GAD1, GAD2), metabolism (ABAT), vesicle transport (SLC32A1),
and re-uptake at the synaptic cleft in neurons (SLC6A1) and glia
(SLC6A11). GABBR1 and GABBR2 that encode the GABAB
presynaptic and postsynaptic receptors were selected. Genes
clustered on chromosomes 4, 5 and 15 that encode the GABAA
postsynaptic receptors were included with the exception of
GABRA6 that is not expressed at detectable levels in the
hippocampus. The trafficking of GABAA receptors is an
important component in the regulation of plasticity of inhibitory
synapses. The intracellular loop of GABAA receptor subunits
provides protein-protein interactive domains involved in regulat-
ing receptor synaptic localization and intracellular trafficking For
the purposes of this study, the genes encoding the key proteins that
regulate synaptic localization were selected from the review by
Chen and Olsen, 2007 [27]: GPHN, NSF, UBQLN1, GABARAP,
RDX and ZDHHC3 (Table 1).
Statistical analyses
Linear regression analyses were performed using JMP v7 with
quantile normalized gene expression values as the dependent
variable and diagnosis, PMI, age, and ethnicity (Caucasian/
Hispanic or African American coded 1 or 2) as the independent
variables. Age, ethnicity and PMI were included in the analyses if
p#0.1.
The aim of this exploratory study was to detect both
overlapping and specific changes in gene expression in cocaine
addicts and alcoholics. Therefore we based our analysis for each
gene on the plots shown in Figures 1, 2 and 3. For example, in
Figure 1 it can be seen that GAD1 and GAD2 have lower
expression in cocaine addicts compared with both alcoholics and
controls. As indicated in Table 2, the predominant analyses were:
cocaine addicts vs. alcoholics+controls (7 analyses) (specific effect);
cocaine addicts+alcoholics vs. controls (7 analyses) (overlapping
effects); alcoholics vs. cocaine addicts+controls (4 analyses) (specific
effect) and cocaine addicts vs. alcoholics (4 analyses) (specific
effect). P values were corrected in the analyses in humans and in
the analyses in P/NP rats using the False Discovery Rate (FDR)
[28] based on 25 candidate genes. Global P values were calculated
using the truncated product method [29], a modified Fisher’s
method (ftp://statgen.ncsu.edu/pub/zaykin/tpm). P values from
all 25 independent tests with P,0.05 were combined and global
significance was assessed by evaluating the distribution of their
product.
Results
Studies in Cocaine Addicts, Alcoholics and Controls
Expression of 16,008 gene transcripts was detected in the
human hippocampus. The scatter plots of log2 transformed,
quantile normalized expression levels of all these gene transcripts
indicate that there is a high correlation between gene expression in




2 GAD1 (GAD67) glutamic acid decarboxylase
3 GAD2 (GAD65) glutamic acid decarboxylase
4 ABAT 4-aminobutyrate aminotransferase (GABA catabolism)
5 SLC32A1 VGAT: vesicular GABA transporter
6 SLC6A1 GAT1: plasma membrane GABA transporter (neurons)
7 SLC6A11 GAT3: plasma membrane GABA transporter (glia)
8 GABBR1 GABAB receptor 1
9 GABBR2 GABAB receptor 2
GABAA receptor subunits
10 GABRG1 Chr4: GABAA c1
11 GABRA2 Chr4: GABAA a2
12 GABRA4 Chr4: GABAA a4
13 GABRB1 Chr4: GABAA b1
14 GABRB2 Chr5: GABAA b2
15 GABRA1 Chr5: GABAA a1
16 GABRG2 Chr5: GABAA c2
17 GABRB3 Chr15: GABAA b3
18 GABRA5 Chr15: GABAA a5
19 GABRG3 Chr15: GABAA c3
GABAA receptor associated proteins
20 GPHN Gephryin
21 NSF NSF: N-ethylmaleimide-sensitive fusion protein
22 UBQLN1 Plic-1: ubiquilin 1
23 GABARAP GABARAP: GABAA receptor associated protein
24 RDX Radixin
25 ZDHHC3 GODZ: zinc finger, DHHC-type containing 3
GABRA6 (chr5) was not expressed at detectable levels in the hippocampal
samples from humans or rats.
doi:10.1371/journal.pone.0029369.t001
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controls (Figure S1).
The global analyses on these 16,008 genes have been previously
reported [1]. Gene expression changes detected by RNA-Seq were
validated by quantitative RT-PCR for 11 transcripts in samples
from eight controls and eight cocaine addicts. There was a strong
correlation (R
2=0.90) between the RNA-Seq and quantitative
RT-PCR measurement indicating overall reliability of the RNA-
Seq results [1].
Figures 4 and S1 indicate that, with the exception of GABRG3,
the remaining 24 GABAergic pathway genes are moderately to
highly expressed in the hippocampus. The highest expression
values were detected for GABBR1 and two genes, NSF and
GABARAP that encode GABAA receptor associated proteins.
Differences in Expression of Gene Transcripts:. Full
statistics, including FDR corrected p values, are presented in
Table 2. Only FDR corrected p values are reported here.
Presynaptic/synaptic genes. From Figure 1A and Table 2
it can be seen that in cocaine addicts there was down-regulation
of GAD1 (p=0.013) and GAD2 (p=0.013). These genes encode
enzymes that synthesize GABA from glutamate. Both cocaine
addicts and alcoholics had lower expression of GABBR1
(p=0.013) (Figures 1A, S2) and a trend (p=0.050) towards
lower expression of SLC6A1 that encodes the GAT1 transporter
that is responsible for re-uptake of GABA from the synaptic
cleft.
GABAA receptor subunit genes. These genes are clustered
on chromosomes 4, 5 and 15. From Table 2 and Figure 2A it can
be seen that alcoholics showed down-regulation of GABRA2
(p=0.028) with a similar trend (p=0.056) for the closely adjacent
GABRG1. GABRG2 was down-regulated in both alcoholics and
cocaine addicts compared with controls (p=0.021) (Figures 2A,
S2). GABRB1 was more highly expressed in cocaine addicts than in
alcoholics (p=0.044).
Genes encoding GABAA receptor associated pro-
teins. From Table 2 and Figure 3A it can be seen that, re-
lative to alcoholics and controls, cocaine addicts showed significant
or trend down-regulation of GPHN (p=0.02), NSF (p,0.001)
(Figure S2), ZDHHC3 (p=0.056) and UBQLN1 (p=0.062).
Alcoholics had increased expression of GABARAP relative to
cocaine addicts (p=0.021).
A summary of the changes in gene expression are depicted in
Figure 5. Figures S3 and S4 show the gene expression results for
each individual cocaine addict, alcoholic and control.
Studies in P and NP Rats
Expression of 11,406 gene transcripts was detected in the rat
hippocampus. It should be noted that the read counts were
Figure 1. The Expression of Presynaptic/Synaptic GABAergic Genes in Human Samples and Rat Samples. ETOH=alcoholics;
CO=cocaine addicts. Error bars: standard errors. ** FDR p,0.05; * FDR p#0.06.
doi:10.1371/journal.pone.0029369.g001
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samples and therefore gene expression levels can only be com-
pared within each dataset and not across the two datasets.
Differences in Expression of Gene Transcripts:. Full
statistics, including FDR corrected p values, are presented in
Table 2. Only FDR corrected p values are reported here.
Presynaptic/synaptic genes. Table 2 and Figure 1B: In
common with the alcoholics and cocaine addicts, P rats show
significant down-regulation of GABBR1 (p=0.025) (Figure S2)
compared with NP rats. In addition, they showed a trend effect for
up-regulation of genes implicated in GABA synthesis: GLS
(p=0.050) and GAD1 (p=0.050) and significant down-regulation
of ABAT (p=0.030) that plays a role in GABA metabolism.
GABAA receptor subunit genes. Similar to the cocaine
addicts and alcoholics, P rats show a significant difference in
expression of GABRG2 (p=0.03). However this gene was up-
regulated in P rats but down-regulated in alcoholics and cocaine
addicts (Figures 2B and S2). P rats also show up-regulation of
GABRG3 (p=0.025) together with a trend down-regulation of
GABRB3 (p=0.050).
Genes encoding GABAA receptor associated proteins. In
P rats, GPHN was up-regulated (p=0.025) relative to NP rats, a
finding that was congruent with the up-regulation of GABRG2.
NSF was down-regulated (p=0.050), a finding that was congruent
with down-regulation of GABBR1 (Figures 3B, S2).
A summary of the changes in gene expression in P rats relative
to NP rats are depicted in Figure 5. Figures S5 and S6 show the
gene expression results for each of the individual P and NP rats.
Global P values
The selected GABAergic genes were strong candidates for
involvement in addiction and in addictive tendencies. Indeed, 14/
25 of the human genes and 12/25 of the rat genes showed
nominally significant differences in gene expression. The global p
value, calculated using the truncated product method [29] for
overall differences in expression of the 25 genes in humans with
alcohol or cocaine addiction compared with controls was
p=9.1610
214. The global p value for overall differences in




The aim of this study of GABAergic gene expression in
postmortem hippocampal samples was to distinguish changes that
were common to both addictions as well as changes that might be
unique to alcoholics or cocaine addicts. Many of these gene
expression changes are likely to reflect tolerance to chronic, heavy
use but it is possible that some differences between dependent
individuals and controls may represent risk factors for addiction.
Figure 2. The Expression of GABAA Receptor Subunit Genes in Human Samples and Rat Samples. The genes are grouped in the
chromosomal 4, 5 and 15 clusters. ETOH=alcoholics; CO=cocaine addicts. Error bars: standard errors. ** FDR p,0.05; * FDR p#0.06.
doi:10.1371/journal.pone.0029369.g002
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effects by comparing gene expression changes in alcoholics and
cocaine addicts versus controls with gene expression changes in
alcohol-naı ¨ve P and NP rats that were selectively bred for extremes
of alcohol consumption behavior and are considered to be a
realistic animal model of human alcohol dependence
[25,26,30,31]. P rats also show addiction vulnerability to other
substances including cocaine [2].
A key finding of our study is that there was a robust down-
regulation of GABBR1 in both alcoholics and cocaine addicts
compared with controls and in P rats compared with NP rats
suggesting that GABBR1 down-regulation could be a predictor for
increased risk for addiction. A congruent finding is that NSF,
which plays a role in the regulation of GABAB receptor signaling
efficacy [32] was also down-regulated in both cocaine addicts and
P rats.
GABAB receptors are ubiquitous G protein-coupled receptors
that are heterodimers of GABAB1 and GABAB2 subunits.
Presynaptic GABAB receptors repress Ca
2+ influx, and therefore
GABA release, by inhibiting the activity of voltage-gated calcium
channels [33,34]. In interpreting the results of our study it should
be borne in mind that we only measured mRNA transcripts and
not protein levels, however if decreased GABBR1 expression results
in down-regulation of GABAB receptors our identical findings in
alcoholics, cocaine addicts and alcohol-naı ¨ve P rats suggest that
this may be a marker for vulnerability to addiction. Indeed,
accumulating evidence from studies in mice and rats (including
Indiana P rats) shows that in the reverse situation of GABAB
receptor up-regulation by agonists such as baclofen, there is a
reduction of drug-related behaviors including alcohol consump-
tion, relapse-like drinking and re-instatement of cocaine seeking
behavior [17,18,35,36,37]. Moreover, baclofen decreases alcohol
consumption, craving and severity of alcohol withdrawal symp-
toms in humans [17,19]. By inference, down-regulation of
GABAB receptors may increase the rewarding effects of drugs of
abuse.
The second robust finding that was common to alcoholics,
cocaine addicts and P rats was altered expression of GABRG2 and
also GPHN (encoding gephryin). GABRG2 encodes the gamma2
subunit, a component of approximately 75% of all neuronal
GABAA receptors that is essential for benzodiazepine sensitivity
[38]. The gamma2 subunit is required for synaptic clustering of
GABAA receptors and for the recruitment to postsynaptic sites of
gephryin, a scaffolding protein that anchors GABAA receptors to
the postsynaptic skeleton [39–43]. Both GABRG2 and GPHN were
significantly up-regulated in alcohol-naı ¨ve P rats relative to NP
rats. In contrast, GABRG2 was significantly down-regulated in
alcoholics and cocaine addicts relative to controls and likewise
Figure 3. The Expression of Genes Encoding GABAA Receptor Associated Proteins in Human Samples and Rat Samples.
ETOH=alcoholics; CO=cocaine addicts. Error bars: standard errors. ** FDR p,0.05; * FDR p#0.06.
doi:10.1371/journal.pone.0029369.g003
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circumstances, only GABAA receptors that include a delta subunit
in place of a gamma2 subunit are responsive to the usually low
extrasynaptic GABA concentrations. However, it has been shown
that increasing the ambient extracellular GABA concentration
results in tonic activation of gamma2 subunit-containing GABAA
extrasynaptic receptors [44,45]. This could be one explanation for
the up-regulation of GABRG2 and GPHN in alcohol naı ¨ve P rats
that, as mentioned earlier, may have chronically increased GABA
levels in the synaptic cleft relative to NP rats. In contrast, the
down-regulation of GABRG2 (and GPHN) in alcoholics and cocaine
addicts might be compensatory and a feature of tolerance to drug.
This is supported by preclinical findings; for example cynomolgus
macaque monkeys allowed to self-administer ethanol for 18
months show reduced gamma2 mRNA expression in the
amygdala [46] and cultured rat hippocampal neurons exposed
to ethanol for 5 days likewise showed reduced gamma2 mRNA
levels [47].
In both alcoholics and cocaine addicts compared with controls
there was a near significant (FDR p=0.050) down-regulation of
SLC6A1 that encodes the principal neuronal GABA transporter
(GAT1). Decreased levels of GAT1 could result in enhanced
extracellular GABA levels, as has been shown to occur in GAT1
deficient mice [12]. Moreover, the effect of tiagabine, a GAT1
inhibitor is to reduce the subjective effects of cocaine in cocaine
addicts [48]. This reduced response to drug or alcohol, i.e.
‘tolerance’, occurs with long-term use. Since there was no
alteration in GAT1 expression in P rats, it is possible that the
changes seen in humans may represent altered homeostasis seen in
drug tolerance [49].
Changes specific to cocaine addiction were the down-regulation
of GAD1 and GAD2, genes that encode glutamic acid decarbox-
ylase, the enzyme responsible for the majority of GABA synthesis
from glutamate in the CNS. The fact that GAT1 deficient mice,
although having enhanced extracellular GABA levels, show
unaltered levels of GAD1 and VGAT [44,50] suggests that this
change in GAD1 expression in cocaine addicts is likely to be
independent and not compensatory for increased synaptic GABA.
It is of interest that GAD1 has also been shown to be down-
regulated in the hippocampus of patients with schizophrenia and
bipolar disorder [51].
Changes specific to alcoholism were the down-regulation of
GABRA2 (FDR p=0.028) and a trend down-regulation of
GABRG1 (FDR p=0.056). These closely adjacent genes in the
Table 2. Analyses of Gene Expression Changes in Human and Rat Hippocampus.
HUMANS P vs NP RATS
Max Effect F (df) P value FDR P F(1,14) P value FDR P
GLS CO vs ETOH F(2,13)=5.4 0.037 0.066 7.3 0.018 0.050
GAD1 CO vs CT+ETOH F(1,22)=12.9 0.002 0.013 7.2 0.018 0.050
GAD2 CO vs CT+ETOH F(2,21)=14.5 0.001 0.013 2.1 0.166 0.244
ABAT CO vs CT F(3,11)=4.6 0.055 0.092 10.7 0.006 0.030
SLC32A1 CO vs ETOH F(2,13)=3.0 0.108 0.166 2.4 0.142 0.222
SLC6A1 CT vs CO+ETOH F(1,22)=6.3 0.020 0.050 4.7 0.047 0.098
SLC6A11 ETOH vs CT+CO F(1,22)=2.5 0.126 0.166 5.7 0.031 0.071
GABBR1 CT vs CO+ETOH F(2,21)=12.8 0.002 0.013 16.4 0.001 0.025
GABBR2 CT vs CO+ETOH F(2,21)=2.6 0.121 0.166 6.3 0.025 0.063
GABRG1 ETOH vs CT+CO F(1,22)=5.8 0.025 0.056 1.9 0.188 0.261
GABRA2 ETOH vs CT+CO F(1,22)=8.3 0.009 0.028 4.2 0.061 0.117
GABRA4 ETOH vs CT+CO F(1,22)=0.8 0.380 0.396 1.6 0.233 0.291
GABRB1 CO vs ETOH F(1,14)=7.5 0.016 0.044 0.0 0.900 0.900
GABRB2 ETOH vs CT+CO F(1,22)=1.3 0.270 0.300 1.6 0.220 0.290
GABRA1 CO vs CT vs ETOH F(2,21)=0.0 0.991 0.991 0.5 0.476 0.541
GABRG2 CT vs CO+ETOH F(2,19)=9.5 0.006 0.021 11.4 0.005 0.030
GABRB3 CT vs CO+ETOH F(3,20)=1.4 0.247 0.294 7.2 0.018 0.050
GABRA5 CT vs CO+ETOH F(1,22)=2.1 0.158 0.198 0.4 0.563 0.612
GABRG3 CT vs CO+ETOH F(2,21)=1.3 0.276 0.300 12.8 0.003 0.025
GPHN CO vs CT+ETOH F(1,22)=10.5 0.004 0.020 15.2 0.002 0.025
NSF CO vs CT+ETOH F(2,21)=23.6 ,0.001 ,0.001 8.0 0.014 0.050
UBQLN1 CO vs CT+ETOH F(2,21)=5.3 0.032 0.062 0.0 0.840 0.875
GABARAP CO vs ETOH F(1,14)=10.8 0.005 0.021 1.1 0.319 0.380
RDX CO vs CT+ETOH F(1,22)=2.5 0.125 0.166 2.6 0.129 0.215
ZDHHC3 CO vs CT+ETOH F(1,22)=5.7 0.027 0.056 3.3 0.091 0.163
Ethnicity, postmortem interval and age were included as covariates in the linear regression analyses if p#0.1.
Both the uncorrected p values and the FDR corrected p values are shown. FDR corrected significant results and trend effects designated as p#0.06 are shown in bold.
The analyses for ‘maximum effect’ in human samples were derived from the plots shown in Figures 1, 2 and 3.
ETOH=alcoholics; CO=cocaine addicts; CT=controls.
doi:10.1371/journal.pone.0029369.t002
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alpha2 and gamma1 subunits that have been robustly associated
with alcohol use disorders and alcohol related phenotypes in
human case-control studies (reviewed in [14]).
Compared with alcoholics, cocaine addicts showed significantly
increased expression of GABRB1 but significantly lower expression
of GABARAP that encodes the protein GABARAP. Some [52] but
not all [53] studies have shown that GABARAP anchors GABAA
receptors to the postsynaptic cytoskeleton via high affinity binding
to the gamma2 subunit and interactions with gephyrin and NSF.
Certainly in cocaine addicts the GABARAP findings are congruent
with those of GPHN and NSF but the relevance of the findings in
alcoholics is not clear.
The Indiana P rats are considered to be a realistic animal model
of human alcohol dependence because of the following features: (a)
they consume 5–8 g of ethanol/kg/day, achieving a BAC of 50–
200 mg% which is equivalent to human consumption of
approximately 8–14 standard drinks/day; (b) they have been
shown to consume ethanol for its CNS effects and not because of
taste, odor or caloric properties and will work to obtain 10–40%
V/V ethanol solutions despite free access to food and water; (c)
they show increased stimulatory responses to low dose ethanol but
lower response to the sedating/motor impairing effects; and (d)
they show evidence of alcohol dependence characterized by:
metabolic and functional tolerance, withdrawal (increased anxiety
and lower seizure threshold) and relapse following prolonged
abstinence [25,26,30,31]. The P rat is more anxious than the NP
rat, as assessed by three different measures, and responds to the
anxiolytic effects of ethanol [54]. Therefore changes in the
GABAergic system were expected. P and NP rats differ in their
hippocampal theta currents [55] and this may be related in part to
the differences in expression of GABBR1 that we noted in our study
[56]. Finally, compared with NP rats, P rats show increased
nicotine self administration and relapse together with increased
cocaine seeking during extinction and cocaine priming-induced
reinstatement i.e. relapse vulnerability, indicating the likelihood of
a general addictive tendency [2].
Some earlier studies have used microarrays to look at genome-
wide differences in gene expression in the hippocampus of alcohol
naı ¨ve P and NP rats [26]. A systems genetic analysis combining
data from five strains of high and low alcohol consuming mice
together with data from rats and humans identified the
GABAergic transmission pathway as critical in the expression of
the quantitative phenotype of alcohol consumption. The list of
candidate genes included ABAT, GAD1 and GABRB2 [57,58]. It is
noteworthy that in our study ABAT and GAD1 also differed in
expression between P and NP rats.
One strength of our study is that the same RNA-Seq method
was used in both human and rat postmortem samples and
therefore comparisons of relative gene expression levels across
humans and across rats were valid. RNA-Seq has a large dynamic
range of expression levels over which transcripts can be detected
unlike DNA microarrays that lack sensitivity for genes expressing
at low or high levels [21]. One caveat for our study is that the
results may be confined to the hippocampus since gene expression
is likely to vary across brain regions [59]. Finally, the aim of this
Figure 4. Expression of GABAergic Pathway Genes in the Human Hippocampus: Cocaine Addicts vs. Controls. The genome-wide
expression levels of 16,008 transcripts, including the 25 GABAergic genes, are shown.
doi:10.1371/journal.pone.0029369.g004
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expression in cocaine addicts and alcoholics. Therefore we did not
automatically perform expression analyses for each gene across all
3 groups (2df). Instead we based our analysis for each gene on the
plots shown in Figures 1, 2 and 3 and as indicated in Table 2. It
could be argued that our FDR correction should have been
greater than for 25 analyses. Nevertheless, the fact that this
exploratory approach yielded results in humans that were
congruent with results in rats suggests that our significant findings
are not likely to be false positives.
In conclusion, our study has shown that, at least within the
hippocampus, chronic alcohol and cocaine exposure results in
both overlapping and specific changes in expression of GABAer-
gic genes. Similar findings in addiction-vulnerable rats provide
clues as to predisposing factors for alcohol and drug addiction.
The selected GABAergic genes were strong candidates for
involvement in addiction and in addictive tendencies. Indeed,
14/25 of the human genes (global p=9.1610
214) and 12/25 of
the rat genes (global p=7.0610
211) showed nominally significant
changes in gene expression. Moreover, there was striking overlap
in human and rat genes that showed no changes in expression; for
example of the genes encoding the GABAA receptor subunits,
changes were largely confined to genes encoding the gamma
subunits and not the alpha or beta subunits (other than alpha2 in
the alcoholics). Finally, it is remarkable that such strong and
consistent findings were evident in the ‘snapshot in time’ captured
in the human mRNA transcripts bearing in mind that other
factors that might alter gene expression including lifetime
stressors were unknown.
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Figure S1 Expression of GABAergic Pathway Genes in
the Human Hippocampus: Alcoholics vs. Controls. The
genome-wide expression levels of 16,008 transcripts, including the
25 GABAergic genes, are shown.
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Figure S2 Congruent Findings in Gene Expression
Changes in Humans and Rats. CO=cocaine addicts
(N=8), CT=controls (N=8), AD=alcoholics (N=8). Alcohol-
naı ¨ve rats: P=alcohol preferring (N=8), NP=non-preferring
(N=8). qNorm=log2 transformed, quantile normalized mRNA
expression levels.
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Figure S3 Gene Expression in Individual Cocaine
Addicts Compared with Individual Controls. CO1–CO9,
CT1–CT9: 8 cocaine addicts and 8 controls respectively.
qNorm=log2 transformed, quantile normalized mRNA expres-
sion levels.
(PDF)
Figure S4 Gene Expression in Individual Alcoholics
Compared with Individual Controls. ETOH1–ETOH8,
CT1–CT9: 8 alcoholics and 8 controls respectively. qNorm=log2
transformed, quantile normalized mRNA expression levels.
(PDF)
Figure S5 Up-Regulated Genes in Individual P Rats
Compared with Individual NP Rats. NP1–NP 8, P1–P8: 8
Figure 5. A Summary of Gene Expression Changes in Human Samples and in P Rats Relative to NP Rats. This schematic summarizes the
gene expression changes shown in Table 2 (FDR p#0.06).
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